Search hospitals > Tennessee > Memphis

St Jude Children's Research Hospital

Claim this profile
Memphis, Tennessee 38105
Global Leader in Tumors
Global Leader in Brain Tumor
Conducts research for Leukemia
Conducts research for Lymphoma
Conducts research for Lymphoblastic Leukemia-Lymphoma
911 reported clinical trials
67 medical researchers
Photo of St Jude Children's Research Hospital in MemphisPhoto of St Jude Children's Research Hospital in MemphisPhoto of St Jude Children's Research Hospital in Memphis

Summary

St Jude Children's Research Hospital is a medical facility located in Memphis, Tennessee. This center is recognized for care of Tumors, Brain Tumor, Leukemia, Lymphoma, Lymphoblastic Leukemia-Lymphoma and other specialties. St Jude Children's Research Hospital is involved with conducting 911 clinical trials across 825 conditions. There are 67 research doctors associated with this hospital, such as Alberto S. Pappo, Jeffrey E. Rubnitz, MD, PhD, Giles Robinson, MD, and Amar Gajjar, MD.

Area of expertise

1Tumors
Global Leader
St Jude Children's Research Hospital has run 164 trials for Tumors. Some of their research focus areas include:
Stage IV
Stage I
NTRK positive
2Brain Tumor
Global Leader
St Jude Children's Research Hospital has run 158 trials for Brain Tumor. Some of their research focus areas include:
BRAF positive
Stage IV
Stage II

Top PIs

Clinical Trials running at St Jude Children's Research Hospital

Acute Myeloid Leukemia
Brain Tumor
Leukemia
Tumors
Rhabdomyosarcoma
Cancer
Acute Lymphoblastic Leukemia
Neurofibromatosis
Myeloid Leukemia
Low Grade Glioma
Image of trial facility.

Venetoclax + Chemotherapy

for Acute Myeloid Leukemia

A study to evaluate if the randomized addition of venetoclax to a chemotherapy backbone (fludarabine/cytarabine/gemtuzumab ozogamicin [GO]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse who are unable to receive additional anthracyclines, or in 2nd relapse.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

TCRγδ T Cells + Blinatumomab

for Blood Cancers

Recruiting1 award Phase 221 criteria
Image of trial facility.

Revumenib + Chemotherapy

for Acute Myeloid Leukemia

This is a research study to find out if adding a new study drug called revumenib to commonly used chemotherapy drugs is safe and if they have beneficial effects in treating patients with acute myeloid leukemia (AML) or acute leukemia of ambiguous lineage (ALAL) that did not go into remission after treatment (refractory) or has come back after treatment (relapsed), and to determine the total dose of the 3-drug combination of revumenib, azacitidine and venetoclax that can be given safely in participants also taking an anti-fungal drug. Primary Objective To determine the safety and tolerability of revumenib + azacitidine + venetoclax in pediatric patients with relapsed or refractory AML or ALAL. Secondary Objectives Describe the rates of complete remission (CR), complete remission with incomplete count recovery (CRi), and overall survival for patients treated with revumenib + azacitidine + venetoclax at the recommended phase 2 dose (RP2D).
Recruiting1 award Phase 110 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at St Jude Children's Research Hospital?
St Jude Children's Research Hospital is a medical facility located in Memphis, Tennessee. This center is recognized for care of Tumors, Brain Tumor, Leukemia, Lymphoma, Lymphoblastic Leukemia-Lymphoma and other specialties. St Jude Children's Research Hospital is involved with conducting 911 clinical trials across 825 conditions. There are 67 research doctors associated with this hospital, such as Alberto S. Pappo, Jeffrey E. Rubnitz, MD, PhD, Giles Robinson, MD, and Amar Gajjar, MD.
Where is St Jude Children's Research Hospital located?
St. Jude Children's Research Hospital is located at 262 Danny Thomas Place, Memphis, TN, approximately 10 miles southeast of downtown Memphis, near the Mississippi River.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at St. Jude Children's Research Hospital, the following contacts are available: - **Financial Assistance**: Contact the Financial Assistance Department at 901-595-5466 or 901-595-0347 for concerns about hospital bill payments. - **Patient Assistance Coordinator**: For financial support during treatment, resource connection, and insurance billing or payment questions, reach out to a patient assistance coordinator at 901-595-3957 or 901-438-2138. - **Hospital Main Line**: For general inquiries, call 866-278-5833. - **Revenue Integrity**: For insurance, pricing, or financial assistance questions, contact Danny Winchester at 901-595-2186 or email RevenueIntegrity@StJude.org.
What insurance does St Jude Children's Research Hospital accept?
St. Jude Children's Research Hospital accepts various insurance plans, covering treatment costs, copayments, deductibles, coinsurance, and any other costs not covered by insurance. The hospital does not bill patients, ensuring care is provided regardless of the ability to pay, through billing insurance plans or covering costs for uninsured patients. Patients are encouraged to review their insurance documents to understand coverage and consult their care team for any coverage concerns.
What awards or recognition has St Jude Children's Research Hospital received?
St. Jude Children's Research Hospital, located in Memphis, Tennessee, is renowned for its innovative Blue-Sky program, which has garnered over $50 million in funding for employee-generated projects. The hospital boasts a four-out-of-four star rating from Charity Navigator and has been recognized as one of America's Best Employers By State by Forbes in 2023.